S1 Development of a confirmatory phase 3, multicentre, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
- Resource Type
- Abstract
- Source
- In
Neuromuscular Disorders March 2014 24 Supplement 1:S31-S31 - Subject
- Language
- ISSN
- 0960-8966